← FDA DRUG APPROVALS

FDA ANDA · ANDA090764

PRAMIPEXOLE DIHYDROCHLORIDE

Sponsor: NATCO PHARMA

APPLICATION
ANDA090764
TYPE
ANDA
ORIGINAL APPROVAL
2010-04-09
LATEST ACTION
2024-03-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PRAMIPEXOLE DIHYDROCHLORIDEDiscontinued
PRAMIPEXOLE DIHYDROCHLORIDE 0.75MG · TABLET · ORAL

Approval history

2024-03-19Labeling · Supplement 13 · standardAP
2024-03-19Labeling · Supplement 11 · standardAP
2024-03-19Labeling · Supplement 9 · standardAP
2024-03-19Labeling · Supplement 10 · standardAP
2015-11-05Labeling · Supplement 8 · standardAP
2015-11-05Labeling · Supplement 6 · standardAP
2013-08-08Labeling · Supplement 4 · standardAP
2010-04-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →